Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irofulven in Metastatic Colorectal Cancer
NCT00003441Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1998
- Primary completion
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irofulven in metastatic colorectal cancer (mCRC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1998; status: completed.
02
Drugs
irofulven
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00003441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003441.